Methods of monitoring glucose levels in a subject and uses thereof
First Claim
1. A method for evaluating compliance with a weight management program in a subject, said method comprising determining a reference range of glucose amounts or concentrations that correspond to achieving a weight management goal in the subject, said range of glucose amounts or concentrations comprising a high threshold glucose value and a low threshold glucose value, monitoring glucose amount or concentration in the subject using a glucose monitoring device that provides frequent measurement or determination of glucose amount or concentration in the subject and provides an alert or alerts when glucose levels fall outside of the reference range;
- maintaining a record of caloric intake; and
comparing said series of glucose amounts or concentrations, said record, and said reference range to evaluate compliance with the reference range of glucose amounts or concentrations to achieve the weight management goal of the subject.
1 Assignment
0 Petitions
Accused Products
Abstract
Methods of frequently monitoring glucose amounts and/or concentrations in a subject who is at risk for hypoglycemia, hyperglycemia, and/or glucose level fluctuations that put the subject at risk are provided. Also provided are methods of monitoring the effects of one or more pharmaceutical compositions on the levels of glucose in a subject.
-
Citations
29 Claims
-
1. A method for evaluating compliance with a weight management program in a subject, said method comprising
determining a reference range of glucose amounts or concentrations that correspond to achieving a weight management goal in the subject, said range of glucose amounts or concentrations comprising a high threshold glucose value and a low threshold glucose value, monitoring glucose amount or concentration in the subject using a glucose monitoring device that provides frequent measurement or determination of glucose amount or concentration in the subject and provides an alert or alerts when glucose levels fall outside of the reference range; -
maintaining a record of caloric intake; and
comparing said series of glucose amounts or concentrations, said record, and said reference range to evaluate compliance with the reference range of glucose amounts or concentrations to achieve the weight management goal of the subject. - View Dependent Claims (2, 3, 4, 29)
-
-
5. A method for monitoring an effect of at least one non-insulin-containing pharmaceutical composition on glucose levels in a subject receiving said pharmaceutical composition, the method comprising,
monitoring glucose amount or concentration in the subject using a glucose monitoring device that provides frequent measurement or determination of glucose amount or concentration in the subject; -
maintaining a record of treatment with the pharmaceutical composition; and
comparing said series of glucose amounts or concentrations and said record to evaluate the effect of the pharmaceutical composition on glucose levels in the subject receiving said pharmaceutical composition, wherein the pharmaceutical composition is not used in the subject for the treatment of diabetes. - View Dependent Claims (6, 7, 8, 9, 10, 11, 12)
-
-
13. A method for improving prognosis and/or reduction of adverse side-effects associated with a disease state or condition in a subject, said method comprising
determining a reference range of glucose amounts or concentrations that correspond to achieving an improved prognosis or reduction of adverse side-effects associated with said disease state or condition in the subject, said range of glucose amounts or concentrations comprising a high threshold glucose value and a low threshold glucose value, monitoring glucose amount or concentration in the subject using a glucose monitoring device that provides frequent measurement or determination of glucose amount or concentration in the subject and provides an alert or alerts when glucose levels fall outside of the reference range; - and
comparing said series of glucose amounts or concentrations and said reference range to evaluate compliance with the reference range of glucose amounts or concentrations to achieve an improved prognosis or reduction of adverse side-effects associated with said disease state or condition in the subject, wherein said disease state or condition is not type I or type II diabetes. - View Dependent Claims (15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)
- and
-
14. (canceled)
Specification